BioForce Nanosciences Holdings, Inc. (BFNH) Aktienanalyse
Nur zu Informationszwecken. Keine Finanzberatung. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Mit einem Kurs von $ ist BioForce Nanosciences Holdings, Inc. (BFNH) ein Consumer Defensive-Unternehmen mit einer Bewertung von 0. Bewertet mit 42/100 (vorsichtig) bei Wachstumspotenzial, finanzieller Gesundheit und Momentum.
Zuletzt analysiert: 15. März 2026BioForce Nanosciences Holdings, Inc. (BFNH) Konsumgueeter-Geschaeftsueberblick
BioForce Nanosciences Holdings, Inc. develops and distributes natural vitamins, minerals, and nutritional supplements, targeting a broad age demographic. The company differentiates itself through private label offerings and the BioForce Eclipse brand, navigating a competitive packaged foods market focused on health and wellness.
Investmentthese
BioForce Nanosciences Holdings, Inc. presents a speculative investment opportunity within the consumer defensive sector. The company's focus on natural supplements aligns with growing health and wellness trends, potentially driving revenue growth. However, the company's small market capitalization of $0.02 billion and negative P/E ratio of -12.67 indicate significant financial challenges. Key value drivers include expanding private label partnerships and increasing online sales. Upcoming catalysts include potential new product launches and expansion into new retail channels. Potential risks include intense competition, limited financial resources, and the inherent volatility of OTC-traded stocks. Investors should carefully consider these factors before investing.
Basierend auf FMP-Finanzdaten und quantitativer Analyse
Wichtige Highlights
- Market capitalization of $0.02 billion indicates a micro-cap company with high growth potential but also high risk.
- Negative P/E ratio of -12.67 reflects current unprofitability, requiring careful monitoring of future earnings potential.
- Beta of -0.77 suggests a potential inverse correlation with the market, which could offer downside protection during market downturns.
- Focus on natural vitamins and supplements aligns with growing consumer demand for health and wellness products.
- The company's reliance on private label products and distributors presents both opportunities and risks in terms of revenue diversification and margin control.
Wettbewerber & Vergleichsunternehmen
Staerken
- Focus on natural and healthy ingredients.
- Private label manufacturing capabilities.
- Established distribution network.
- Brand recognition through BioForce Eclipse.
Schwaechen
- Small market capitalization.
- Limited financial resources.
- Negative P/E ratio indicating unprofitability.
- Reliance on third-party distributors.
Katalysatoren
- Upcoming: Potential new product launches in the natural supplement category, targeting specific health needs.
- Ongoing: Expansion of private label partnerships with retailers and distributors.
- Ongoing: Increased online sales through targeted marketing campaigns and e-commerce optimization.
Risiken
- Potential: Intense competition from larger, more established players in the supplement industry.
- Potential: Changing consumer preferences and trends in the health and wellness market.
- Ongoing: Limited financial resources and potential difficulty in raising capital.
- Ongoing: Regulatory changes and compliance requirements affecting the supplement industry.
- Potential: Economic downturn affecting consumer spending on non-essential products.
Wachstumschancen
- Expansion of Private Label Partnerships: BioForce Nanosciences can increase revenue by securing additional private label contracts with retailers and distributors. The private label market is projected to reach $250 billion by 2028, offering significant growth potential. Success depends on competitive pricing, product quality, and reliable supply chain management. Timeline: Ongoing.
- Increased Online Sales: The company can leverage the growing e-commerce market to expand its reach and increase sales. The online supplement market is expected to grow by 10% annually, reaching $40 billion by 2027. Investing in a user-friendly website, targeted marketing campaigns, and efficient order fulfillment are crucial. Timeline: Ongoing.
- New Product Development: Introducing innovative and specialized nutritional supplements can attract new customers and increase market share. The market for personalized nutrition is expanding rapidly, driven by advancements in genomics and data analytics. Focusing on niche markets, such as sports nutrition or senior health, can provide a competitive advantage. Timeline: Upcoming, within 12-18 months.
- Strategic Acquisitions: Acquiring smaller supplement companies or specialized ingredient suppliers can expand product offerings and improve supply chain control. The fragmented supplement industry presents numerous acquisition opportunities. Careful due diligence and integration planning are essential for success. Timeline: Potential, within 24-36 months.
- Geographic Expansion: Expanding into new geographic markets, particularly in Asia and Europe, can significantly increase revenue. The global supplement market is expected to reach $280 billion by 2028, with strong growth in emerging markets. Adapting product formulations to local preferences and navigating regulatory requirements are key considerations. Timeline: Potential, within 36-48 months.
Chancen
- Expansion of private label partnerships.
- Increased online sales through e-commerce.
- New product development and innovation.
- Strategic acquisitions of smaller companies.
Risiken
- Intense competition in the supplement industry.
- Changing consumer preferences and trends.
- Regulatory changes and compliance requirements.
- Economic downturn affecting consumer spending.
Wettbewerbsvorteile
- Brand recognition through the BioForce Eclipse brand.
- Private label manufacturing capabilities.
- Established distribution network with retailers and online channels.
Ueber BFNH
BioForce Nanosciences Holdings, Inc., based in Virginia Beach, Virginia, is a provider of natural vitamins, minerals, and nutritional supplements. The company focuses on developing and distributing products aimed at individuals across various age ranges, emphasizing health and wellness. BioForce Nanosciences operates primarily through private label partnerships, collaborating with distributors and manufacturing providers to create custom formulations. Its own brand, BioForce Eclipse, is sold through a variety of channels, including retailers, sporting goods stores, supermarkets, mass merchandisers, and online platforms, as well as through telemarketing efforts. The company's business model centers around offering both branded and private label nutritional supplements. This allows it to cater to a diverse range of customers, from large retail chains seeking to offer their own branded products to individual consumers looking for specific health and wellness solutions. The company's focus on natural ingredients aligns with growing consumer demand for healthier food and supplement options. However, the company's small size and limited resources present challenges in competing with larger, more established players in the packaged foods and supplement industry. The company's success depends on its ability to effectively manage its supply chain, maintain product quality, and adapt to changing consumer preferences in the dynamic health and wellness market.
Was das Unternehmen tut
- Develops natural vitamins and minerals.
- Offers nutritional supplements for various age ranges.
- Provides private label product manufacturing.
- Distributes products under the BioForce Eclipse brand.
- Sells to retailers, sporting goods stores, and supermarkets.
- Markets products online and through telemarketing.
Geschaeftsmodell
- Develops and manufactures natural vitamins and supplements.
- Offers private label manufacturing services to distributors and retailers.
- Sells branded products through retail channels and online platforms.
Branchenkontext
BioForce Nanosciences Holdings, Inc. operates within the competitive packaged foods industry, specifically targeting the nutritional supplements market. This market is characterized by increasing consumer awareness of health and wellness, driving demand for natural and organic products. The industry includes major players like CFOO, DTEAF, ELAMF, HNFSA, and INBP, as well as numerous smaller companies. BioForce Nanosciences competes by offering both branded and private label products, focusing on quality and natural ingredients. The company's success depends on its ability to differentiate itself in a crowded market and effectively reach its target customers.
Wichtige Kunden
- Retailers seeking private label nutritional supplements.
- Sporting goods stores and supermarkets.
- Individual consumers looking for natural vitamins and minerals.
Finanzdaten
Chart & Info
BioForce Nanosciences Holdings, Inc. (BFNH) Aktienkurs: Price data unavailable
Aktuelle Nachrichten
Keine aktuellen Nachrichten fuer BFNH verfuegbar.
Analystenkonsens
Konsens-Bewertung
Aggregierte Kauf-/Halten-/Verkauf-Empfehlungen von Benzinga, Yahoo Finance und Finnhub fuer BFNH.
Kursziele
Wall-Street-Kurszielanalyse fuer BFNH.
MoonshotScore
Was bedeutet diese Bewertung?
Der MoonshotScore bewertet das Wachstumspotenzial von BFNH auf einer Skala von 0-100 ueber mehrere Faktoren wie Innovation, Marktdisruption, finanzielle Gesundheit und Momentum.
Fuehrung: Steven Gagnon
CEO
Steven Gagnon serves as the CEO of BioForce Nanosciences Holdings, Inc. His leadership is focused on guiding the company's strategic direction and overseeing its operations in the nutritional supplement market. With a small team of three employees, Gagnon's role encompasses a wide range of responsibilities, from product development and marketing to sales and distribution. His experience in the consumer goods sector is crucial for navigating the competitive landscape and driving growth.
Erfolgsbilanz: Under Steven Gagnon's leadership, BioForce Nanosciences has focused on expanding its private label partnerships and increasing its online presence. Key milestones include the development of new product formulations and the establishment of relationships with key retailers and distributors. The company's success depends on Gagnon's ability to effectively manage resources and adapt to changing market conditions.
BFNH OTC-Marktinformationen
The OTC Other tier represents the lowest tier of the OTC market, indicating that BioForce Nanosciences Holdings, Inc. may not meet the minimum financial standards or disclosure requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be required to provide regular financial reports, increasing the risk for investors due to lack of transparency. Investing in OTC Other stocks requires a higher level of due diligence and awareness of potential risks.
- OTC-Stufe: OTC Other
- Offenlegungsstatus: Unknown
- Limited financial disclosure increases the risk of investing due to lack of transparency.
- Low trading volume can lead to price volatility and difficulty in buying or selling shares.
- OTC Other stocks may be subject to less regulatory oversight, increasing the potential for fraud or manipulation.
- The company may not meet the minimum financial standards of higher-tier exchanges, indicating potential financial instability.
- Limited analyst coverage and public information can make it difficult to assess the company's true value and prospects.
- Verify the company's registration and legal standing with the relevant regulatory authorities.
- Obtain and review any available financial statements, including balance sheets, income statements, and cash flow statements.
- Assess the company's management team and their experience in the industry.
- Research the company's products or services and their competitive positioning in the market.
- Evaluate the company's business model and its ability to generate sustainable revenue and profits.
- Determine the level of trading volume and liquidity for the stock.
- Understand the risks associated with investing in OTC Other stocks and the potential for loss.
- The company has an established website and online presence.
- The company has been in operation for several years.
- The company has a registered business address and contact information.
- The company offers tangible products or services.
- The company has a management team in place.
BFNH Consumer Defensive Aktien-FAQ
What are the key factors to evaluate for BFNH?
BioForce Nanosciences Holdings, Inc. (BFNH) currently holds an AI score of 42/100, indicating low score. Key strength: Focus on natural and healthy ingredients.. Primary risk to monitor: Potential: Intense competition from larger, more established players in the supplement industry.. This is not financial advice.
How frequently does BFNH data refresh on this page?
BFNH prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven BFNH's recent stock price performance?
Recent price movement in BioForce Nanosciences Holdings, Inc. (BFNH) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Focus on natural and healthy ingredients.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider BFNH overvalued or undervalued right now?
Determining whether BioForce Nanosciences Holdings, Inc. (BFNH) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying BFNH?
Before investing in BioForce Nanosciences Holdings, Inc. (BFNH), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding BFNH to a portfolio?
Potential reasons to consider BioForce Nanosciences Holdings, Inc. (BFNH) depend on individual investment goals and risk tolerance. A key strength identified by analysis: Focus on natural and healthy ingredients.. Additionally: Private label manufacturing capabilities.. Always weigh potential rewards against risks and diversify across holdings. This is not financial advice.
Can I buy fractional shares of BFNH?
Yes, most major brokerages offer fractional shares of BioForce Nanosciences Holdings, Inc. (BFNH) with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track BFNH's earnings and financial reports?
BioForce Nanosciences Holdings, Inc. (BFNH) reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for BFNH earnings announcements is recommended.
Haftungsausschluss: Dieser Inhalt dient ausschliesslich zu Informationszwecken und stellt keine Anlageberatung dar. Fuehren Sie immer Ihre eigene Recherche durch und konsultieren Sie einen Finanzberater.
Offizielle Ressourcen
Daten dienen ausschliesslich zu Informationszwecken.
- Limited information available due to OTC listing and small market capitalization.
- Financial data may not be fully up-to-date or audited.